zoledronic acid has been researched along with Leucocythaemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, S; Kuroda, J; Maekawa, T; Nogawa, M; Ottmann, OG; Sato, K; Segawa, H; Yuasa, T | 1 |
| Colao, A; Lombardi, G; Ricci, P; Rotoli, B; Selleri, C; Serio, B; Tauchmanovà, L | 1 |
1 trial(s) available for zoledronic acid and Leucocythaemia
| Article | Year |
|---|---|
Short-term zoledronic acid treatment increases bone mineral density and marrow clonogenic fibroblast progenitors after allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Bone Density; Bone Marrow Cells; Diphosphonates; Female; Fibroblasts; Humans; Imidazoles; Infusions, Intravenous; Leukemia; Male; Middle Aged; Osteoporosis; Stem Cell Transplantation; Stem Cells; Transplantation, Homologous; Zoledronic Acid | 2005 |
1 other study(ies) available for zoledronic acid and Leucocythaemia
| Article | Year |
|---|---|
Antiproliferative efficacy of the third-generation bisphosphonate, zoledronic acid, combined with other anticancer drugs in leukemic cell lines.
Topics: Antineoplastic Agents; Benzamides; Cell Death; Cell Division; Cell Line, Tumor; Cytarabine; Daunorubicin; Diphosphonates; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Hydroxyurea; Imatinib Mesylate; Imidazoles; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Piperazines; Pyrimidines; Vincristine; Zoledronic Acid | 2004 |